Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Die Folgen des Klimwandels haben einen direkten Einfluss auf die Primärversorgung in Deutschland: Hitzeschutz insbesondere bei älteren Patienten, die Zunahme von Infektionen und die Verlängerung der Allergiesesaison spielen medizinisch eine bedeutsame Rolle. Aber auch in der Prävention und der Aufklärung der Patienten kommt den Hausärztinnen und -ärzten eine besondere Rolle zu. Direkt aus der Praxis berichtet im Live-Webinar am 13. Mai von 18 bis 19 Uhr unser Experte Dr. med. Robin Maitra.
Erweiterte Suche
Anmelden
nach oben
Clinical Reviews in Allergy & Immunology
Erschienen in: Clinical Reviews in Allergy & Immunology 1/2014

01.08.2014

Recommendations for the Management of Beta-Lactam Intolerance

verfasst von: Eric Macy, Eunis Ngor

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Beta-lactam intolerance, most of which is not IgE or even immunologically mediated even though it is commonly called an “allergy,” can be safely managed using the following seven steps:
1.
Avoid testing, re-challenging, or desensitizing individuals with histories of beta-lactam associated toxic epidermal necrolysis, Stevens–Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, severe hepatitis, interstitial nephritis, or hemolytic anemia.
 
2.
Avoid unnecessary antibiotic use, especially in the setting of viral infections.
 
3.
Expect new intolerances to be reported after 0.5 to 4 % of all antibiotic utilizations, dependent on gender and the specific antibiotic used.
 
4.
Expect a higher incidence of new intolerances in individuals with three or more medication intolerances already noted in their medical records.
 
5.
For individuals with an appropriate penicillin class antibiotic intolerance based on a history of anaphylaxis, urticaria, macular papular rashes, unknown symptoms, or symptoms not excluded in step one, proceed with penicillin skin testing. Skin test with penicilloyl-poly-lysine and native penicillin. If skin test is negative, proceed with an oral amoxicillin challenge. If skin test and oral challenge are negative, penicillin class antibiotics may be used. If skin test or oral challenge is positive, avoid penicillin class antibiotics. If skin test or oral challenge is positive, non-penicillin-beta-lactams may be used, unless there is a history of intolerance to a specific non-penicillin-beta-lactam, then avoid that specific non-penicillin-beta-lactam. If there is life-threatening infection that can only be treated with a penicillin class antibiotic, proceed with oral penicillin desensitization prior to any oral or parenteral penicillin use.
 
6.
For individuals with an appropriate non-penicillin-beta-lactam intolerance, avoid re-exposure to the beta-lactam implicated. An alternative beta-lactam may be used, ideally with different side chains. Penicillin allergy testing is not useful in the management of non-penicillin-beta-lactam intolerance. Non-penicillin-beta-lactam skin testing is not clinically useful and should not be done outside of a research setting. If the non-penicillin-beta-lactam implicated is needed to treat a life-threatening infection, proceed with desensitization.
 
7.
Be ready to treat anaphylaxis with all parenteral beta-lactam use.
 
Literatur
1.
Little P, Stuart B, Moore M, on behalf of the GRACE consortium et al (2013) Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 13:123–129PubMedCrossRef
2.
Idsoe O, Guthe T, Willcox RR, De Weck AL (1968) Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull Wld Hlth Org 38:159–188
3.
Clemens JD, Ransohoff DF (1984) A quantitative assessment of pre-dental antibiotic prophylaxis for patients with metal-valve prolapse. J Chronic Dis 37:531–534PubMedCrossRef
4.
Lee P, Shanson D (2007) Results of a UK survey of fatal anaphylaxis after oral amoxicillin. J Antimicrob Chemother 60:1172–1179PubMedCrossRef
5.
Levine BB (1973) Antigenicity and cross-reactivity of penicillins and cephalosporins. J Inf Dis 128:s364–s366CrossRef
6.
Sogn DD, Evens R III, Shepard GM, Csale TB, Codemi J, Greenberger PA, Kohler PF, Saxon A, Summers RJ, VanArsdel PP, Massicot JG, Blackwelder WC, Levine BB (1992) Results of the National Institute of Allergy and Infectious diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 152:1025–1032PubMedCrossRef
7.
Caubet JC, Kaiser L, Lemaitre B, Fellay B, Gervaix A, Eigenmann PA (2011) The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. J Allergy Clin Immunol 127:218–222PubMedCrossRef
8.
Romano A, Gaeta F, Valluzzi R, Caruso C, Rumi G, Bousquet P (2010) IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems. J Allergy Clin Immunol 126:994–999PubMedCrossRef
9.
Buonomo A, Nucera E, De Pasquale T, Pecora V, Lombardo C, Sabato V, Colagiovanni A, Rizzi A, Aruanno A, Pascolini L, Patriarca G, Schiavino D (2011) Tolerability of aztreonam in patients with cell-mediated allergy to β-lactams. Int Arch Allergy Immunol 155:155–159PubMedCrossRef
10.
Liu X, Gao N, Qiao H (2011) Cephalosporin and penicillin cross-reactivity in patients allergic to penicillins. Int J Clin Pharmacol Ther 49:206–216PubMedCrossRef
11.
Antunez C, Blanca-Lopez N, Torres MJ, Mayorga C, Perez-Inestrosa E, Montanez MI, Fernandez T, Blanca M (2006) Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol 117:404–410PubMedCrossRef
12.
Guéant J, Guéant-Rodriguez R, Viola M, Valluzzi R, Romano A (2006) IgE-mediated hypersensitivity to cephalosporins. Curr Pharm Des 12:3335–3345PubMedCrossRef
13.
Baldo BA, Pham NH (2002) Immunoglobulin E binding determinants on beta-lactam drugs. Curr Opin Allergy Clin Immunol 2:297–300PubMedCrossRef
14.
DePestel D, Benninger M, Danziger L, LaPlante K, May C, Luskin A, Pichichero M, Hadley J (2008) Cephalosporin use in treatment of patients with penicillin allergies. J Am Pharm Assoc 48:530–540CrossRef
15.
Caimmi S, Caimmi D, Lombardi E, Crisafulli G, Franceschini F, Ricci G, Marseglia G (2011) Antibiotic allergy. Int J Immunopathol Pharmacol 24(3 Suppl):S47–S53PubMed
16.
Solensky R (2003) Hypersensitivity reactions to beta-lactam antibiotics. Clin Rev Allergy Immunol 24:201–219PubMedCrossRef
17.
Yates AB (2008) Management of patients with a history of allergy to beta-lactam antibiotics. Am J Med 121:572–576PubMedCrossRef
18.
Lagace-Wiens P, Rubinstein E (2012) Adverse reactions to beta-lactam antimicrobials. Expert Opin Drug Saf 11:381–399PubMedCrossRef
19.
Ponvert C, Weilenmann C, Wassenberg J, Walecki P, Bourgeois M, de Blic J, Scheinmann P (2007) Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge tests. Allergy 62:42–46PubMedCrossRef
20.
Macy E, Poon KWT (2009) Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med 122:778e1–e7CrossRef
21.
Macy E, Ho NJ (2012) Multiple drug intolerance syndrome: prevalence, clinical characteristics and management. Ann Allergy Asthma Immunol 108:88–93PubMedCrossRef
22.
Renn CN, Straff W, Dorfmuller A, Al-Masaoudi T, Merk HF, Sachs B (2002) Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Derm 147:1166–1170CrossRef
23.
Viola M, Quaratino D, Gaeta F, Valluzzi RL, Caruso C, Rumi G, Romano A (2005) Allergic reactions to antibiotics, mainly beta-lactams: facts and controversies. Eur Ann Allergy Clin Immunol 37:223–229PubMed
24.
Atanaskovic-Markovic M (2011) Educational case series: beta-lactam allergy and cross-reactivity. Ped Allergy Immunol 22:770–775CrossRef
25.
Torres MJ, Blanca M (2010) The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavans. Med Clin N Am 94:805–820PubMedCrossRef
26.
Palma-Carlos ML, Palma-Carlos AG, Medina M (2007) “In vivo” and “in vitro” tests in the diagnosis of beta-lactams allergy. Eur Ann Allergy Clin Immunol 39:157–161PubMed
27.
Silva R, Cruz L, Botelho C, Castro E, Cadinha S, Castel-Branco MG, Rodrigues J (2009) Immediate hypersensitivity to penicillins with negative skin tests – the value of specific IgE. Eur Ann Allergy Clin Immunol 41:117–119PubMed
28.
Fontaine C, Mayorga C, Bousquet PJ, Arnoux B, Torres MJ, Blanca M, Demoly P (2007) Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy 62:47–52PubMedCrossRef
29.
30.
Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P (2007) Oral challenge are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy 38:185–190PubMed
31.
Bousquet PJ, Kvedariene V, Co-Minh HB, Martins P, Rongier M, Arnoux B, Demoly P (2007) Clinical presentation and time course in hypersensitivity reactions to beta-lactams. Allergy 62:872–876PubMedCrossRef
32.
Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology (2010) Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 105:259–273, 273e1-e78CrossRef
33.
Adkinson NF Jr, Thompson WL, Maddrey WC, Lichtenstein LM (1971) Routine use of penicillin skin testing on an inpatient service. N Engl J Med 285:22–24PubMedCrossRef
34.
Macy E, Schatz M, Lin C, Poon KWT (2009) The falling rate of positive penicillin skin tests from 1995 to 2007. Permanente J 13:12–18
35.
Jost BC, Wedner HJ, Bloomberg GR (2006) Elective penicillin skin testing in a pediatric outpatient setting. Ann Allergy Asthma Immunol 97:807–812PubMedCrossRef
36.
Park M, Markus P, Matesic D, Li JTC (2006) Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 97:681–687PubMedCrossRef
37.
Lin E, Saxon A, Riedl M (2010) Penicillin allergy: value of including amoxicillin as a determinant in penicillin skin testing. Int Arch Allergy Immunol 152:313–318PubMedCrossRef
38.
Macy E, Ngor EW (2013) Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. J Allergy Clin Immunol In Practice (in press)
39.
Macy E, Burchette RJ (2002) Oral antibiotic adverse reactions after penicillin testing: multi-year follow-up. Allergy 57:1151–1158PubMedCrossRef
40.
Pichichero ME, Casey JR (2007) Safe use of selected cephalosporins in penicillin-allergic patients: meta-analysis. Otolaryngol Head Neck Surg 136:340–347PubMedCrossRef
41.
Macy E, Ho NJ (2011) Adverse reactions associated with therapeutic antibiotic use after penicillin skin testing. Perm J 15:31–37PubMedCentralPubMed
42.
Macy E, Goldberg B, Poon KWT (2010) Use of commercial anti-penicillin-IgE FEIAs to diagnose penicillin allergy. Ann Allergy Asthma Immunol 105:136–141PubMedCrossRef
43.
Raja A, Lindsell CJ, Bernstein JA, Codispoti CD, Moellman JJ (2008) The use of penicillin skin testing to assess the prevalence of penicillin allergy in an emergency department setting. Ann Emerg Med 54:72–77CrossRef
44.
Romano A, Bousquet-Rouanet L, Viola M, Gaeta F, Demoly P, Bousquet PJ (2009) Benzylpenicillin skin testing is still important in diagnosing immediate hypersensitivity reactions to penicillin. Allergy 64:249–253PubMedCrossRef
45.
Torres MJ, Romano A, Blanca-Lopez N, Dona I, Canto G, Ariza A, Aranda A, Montanez MI, Mayorga C, Blanca M (2011) Immunoglobulin E-mediated hypersensitivity to amoxicillin: in vivo and in vitro comparative studies between an injectable therapeutic compound and a new commercial compound. Clin Exp Allergy 41:1595–1601PubMedCrossRef
46.
Mark MA, Koch CA, Klemawesch P, Joshi A, Li JT (2010) Increased adverse drug reactions to cephalosporins in penicillin allergy patients with positive penicillin skin test. Int Arch Allergy Immunol 153:268–273CrossRef
47.
Park MA, Matesic D, Markus PJ, Li JTC (2007) Female sex as a risk factor for penicillin allergy. Ann Allergy Asthma Immunol 99:54–58PubMedCrossRef
48.
Macy E (2011) The clinical evaluation of penicillin allergy: what is necessary, sufficient, and safe given the materials currently available? Clin Exp Allergy 41:1498–1501PubMedCrossRef
49.
Macy E, Richter PK, Falkoff R, Zeiger RS (1997) Skin testing with penicilloate and penilloate prepared by an improved method: amoxicillin oral challenge in patients with negative skin test responses to penicillin reagents. J Allergy Clin Immunol 100:586–591PubMedCrossRef
50.
Macy E (2011) Penicillin allergy might not be very common in subjects with cephaloszorin allergy. J Allergy Clin Immunol 127:1638PubMedCrossRef
51.
Romano A, Gaeta F, Valluzzi RL, Caruso C, Rumi G, Bousquet PJ (2011) Reply. J Allergy Clin Immunol 127:1638–1639CrossRef
52.
Macy E, Mangat R, Burchette RJ (2003) Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins. J Allergy Clin Immunol 111:1111–1115PubMedCrossRef
53.
Patriarca G, Schiavino D, Lombardo C, Altomonte G, De Cinti M, Buonomo A, Nucera E (2008) Tolerability of aztreonam in patients with IgE-mediated hypersensitivity to beta-lactams. Int J Immunopathol Pharmacol 21:375–379PubMed
54.
Buonomo A, Nucera E, De Pasquale T, Pecora V, Lombardo C, Sabato V, Colgiovanni A, Rizzi A, Aruanno A, Pascolini L, Patriarca G, Schiavino D (2011) Tolerabilty of aztreonam in patients with cell-mediated allergy to beta-lactams. Int Arch Allergy Immunol 155:155–159PubMedCrossRef
Metadaten
Titel
Recommendations for the Management of Beta-Lactam Intolerance
verfasst von
Eric Macy
Eunis Ngor
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 1/2014
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-013-8369-8

Weitere Artikel der Ausgabe 1/2014

Clinical Reviews in Allergy & Immunology 1/2014 Zur Ausgabe

Erratum

Erratum to: Infectious Aspects and the Etiopathogenesis of Rheumatoid Arthritis

OriginalPaper

Hypersensitivity Reactions to Corticosteroids

OriginalPaper

Rheumatoid Arthritis Bone Fragility Is Associated With Upregulation of IL17 and DKK1 Gene Expression

OriginalPaper

Cytokine Gene Considerations in Giant Cell Arteritis: IL10 Promoter Polymorphisms and a Review of the Literature

ReviewPaper

The Clinical Significance of Posttranslational Modification of Autoantigens

ReviewPaper

Semaphorins: Their Dual Role in Regulating Immune-Mediated Diseases

Neu im Fachgebiet HNO

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise